GI
CVS icon

GS Investments’s CVS Health CVS Stock Holding History

GS Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,850
Closed -$706K – 133
2024
Q1 		$706K Hold
8,850
– – 0.34% 62
2023
Q4 		$699K Hold
8,850
– – 0.37% 61
2023
Q3 		$618K Hold
8,850
– – 0.35% 62
2023
Q2 		$612K Hold
8,850
– – 0.33% 64
2023
Q1 		$658K Hold
8,850
– – 0.38% 64
2022
Q4 		$825K Hold
8,850
– – 0.51% 56
2022
Q3 		$844K Hold
8,850
– – 0.56% 54
2022
Q2 		$844K Hold
8,850
– – 0.48% 57
2022
Q1 		$901K Hold
8,850
– – 0.51% 55
2021
Q4 		$913K Hold
8,850
– – 0.44% 58
2021
Q3 		$751K Buy
+8,850
New +$741K 0.39% 61
2021
Q1 		– Sell
-7,640
Closed -$522K – 75
2020
Q4 		$522K Buy
+7,640
New +$497K 0.51% 53
2020
Q3 		– Sell
-10,405
Closed -$676K – 71
2020
Q2 		$676K Hold
10,405
– – 0.54% 43
2020
Q1 		$617K Sell
10,405
-9,095
-47% -$607K 0.61% 44
2019
Q4 		$1.25M Sell
19,500
-4,775
-20% -$335K 1.04% 36
2019
Q3 		$1.53M Hold
24,275
– – 1.12% 31
2019
Q2 		$1.32M Buy
24,275
+30
+0.1% +$1.62K 1.08% 35
2019
Q1 		$1.31M Buy
24,245
+5,375
+28% +$332K 1.03% 40
2018
Q4 		$1.24M Sell
18,870
-545
-3% -$40.7K 1.04% 37
2018
Q3 		$1.53M Sell
19,415
-360
-2% -$25.7K 1.07% 38
2018
Q2 		$1.27M Sell
19,775
-455
-2% -$30K 0.95% 39
2018
Q1 		$1.26M Buy
20,230
+90
+0.4% +$6.46K 0.92% 42
2017
Q4 		$1.46M Buy
20,140
+635
+3% +$46.2K 1.11% 37
2017
Q3 		$1.59M Hold
19,505
– – 1.27% 29
2017
Q2 		$1.57M Buy
+19,505
New +$1.54M 1.18% 29

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

GS Investments's CVS Position: Q2 2024 in Review

GS Investments sold out of CVS Health (CVS) in Q2 2024, closing a stake of 8,850 shares — an estimated $706K sold.

GS Investments first reported a position in CVS in Q2 2017 and held it in 25 quarters. The position peaked at $1.59M in Q3 2017. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • GS Investments reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • GS Investments sold 8,850 CVS Health shares in Q2 2024, an estimated $706K.
  • GS Investments first reported a position in CVS Health in Q2 2017 and held it in 25 quarters.
  • GS Investments's CVS Health position peaked at $1.59M in Q3 2017.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on GS Investments's 13F filing for Q2 2024, filed 31 Jul 2024.